Correlation Between GlaxoSmithKline PLC and Rapport Therapeutics,
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Rapport Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Rapport Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Rapport Therapeutics, Common, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Rapport Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Rapport Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Rapport Therapeutics,.
Diversification Opportunities for GlaxoSmithKline PLC and Rapport Therapeutics,
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between GlaxoSmithKline and Rapport is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Rapport Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics, and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Rapport Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics, has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Rapport Therapeutics, go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Rapport Therapeutics,
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Rapport Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 3.63 times less risky than Rapport Therapeutics,. The stock trades about -0.04 of its potential returns per unit of risk. The Rapport Therapeutics, Common is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 2,052 in Rapport Therapeutics, Common on November 3, 2024 and sell it today you would lose (411.00) from holding Rapport Therapeutics, Common or give up 20.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.2% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Rapport Therapeutics, Common
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Rapport Therapeutics, |
GlaxoSmithKline PLC and Rapport Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Rapport Therapeutics,
The main advantage of trading using opposite GlaxoSmithKline PLC and Rapport Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Rapport Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will offset losses from the drop in Rapport Therapeutics,'s long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Rapport Therapeutics, vs. Copperbank Resources Corp | Rapport Therapeutics, vs. Molecular Partners AG | Rapport Therapeutics, vs. Centessa Pharmaceuticals PLC | Rapport Therapeutics, vs. Uber Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |